Cargando…
Efficacy and pharmacokinetic evaluation of a novel anti-malarial compound (NP046) in a mouse model
BACKGROUND: Even though malaria is a completely preventable and treatable disease, it remains a threat to human life and a burden to the global economy due to the emergence of multiple-drug resistant malaria parasites. According to the World Malaria Report 2013, in 2012 there were an estimated 207 m...
Autores principales: | Abay, Efrem T, van der Westuizen, Jan H, Swart, Kenneth J, Gibhard, Liezl, Lawrence, Nina, Dambuza, Ntokozo, Wilhelm, Anke, Pravin, Kendrekar, Wiesner, Lubbe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326489/ https://www.ncbi.nlm.nih.gov/pubmed/25563929 http://dx.doi.org/10.1186/1475-2875-14-8 |
Ejemplares similares
-
The development and validation of an LC-MS/MS method for the determination of a new anti-malarial compound (TK900D) in human whole blood and its application to pharmacokinetic studies in mice
por: Abay, Efrem T, et al.
Publicado: (2014) -
Antiplasmodial activity, in vivo pharmacokinetics and anti-malarial efficacy evaluation of hydroxypyridinone hybrids in a mouse model
por: Dambuza, Ntokozo S., et al.
Publicado: (2015) -
A Pharmacokinetic Study of Antimalarial 3,5-Diaryl-2-aminopyridine Derivatives
por: Dambuza, Ntokozo, et al.
Publicado: (2015) -
The evaluation of ADME and pharmacokinetic properties of decoquinate derivatives for the treatment of malaria
por: Watson, Daniel J., et al.
Publicado: (2022) -
Toward New Transmission-Blocking Combination Therapies: Pharmacokinetics of 10-Amino-Artemisinins and 11-Aza-Artemisinin and Comparison with Dihydroartemisinin and Artemether
por: Watson, Daniel J., et al.
Publicado: (2021)